Maccura Biotechnology Co.Ltd (300463.SZ)
CNY 12.06
(0.08%)
CNY 12.06
(0.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 312.61 Million CNY | -55.86% |
| 2022 | 708.18 Million CNY | -25.97% |
| 2021 | 956.6 Million CNY | 20.49% |
| 2020 | 793.91 Million CNY | 51.15% |
| 2019 | 525.26 Million CNY | 18.06% |
| 2018 | 444.92 Million CNY | 18.92% |
| 2017 | 374.13 Million CNY | 19.91% |
| 2016 | 312.02 Million CNY | 24.29% |
| 2015 | 251.04 Million CNY | 10.98% |
| 2014 | 226.21 Million CNY | 17.11% |
| 2013 | 193.15 Million CNY | 22.09% |
| 2012 | 158.2 Million CNY | 31.39% |
| 2011 | 120.41 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 120.44 Million CNY | 174.1% |
| 2024 Q2 | 81.28 Million CNY | -32.51% |
| 2024 Q3 | 79.64 Million CNY | -2.01% |
| 2023 Q4 | 43.94 Million CNY | -53.17% |
| 2023 Q1 | 116.87 Million CNY | 8.9% |
| 2023 Q2 | 57.96 Million CNY | -50.41% |
| 2023 Q3 | 93.84 Million CNY | 61.9% |
| 2023 FY | 312.61 Million CNY | -55.86% |
| 2022 Q2 | 203.92 Million CNY | 1.03% |
| 2022 Q1 | 201.84 Million CNY | 25.8% |
| 2022 FY | 708.18 Million CNY | -25.97% |
| 2022 Q4 | 107.31 Million CNY | -44.93% |
| 2022 Q3 | 194.86 Million CNY | -4.44% |
| 2021 Q1 | 313.33 Million CNY | 37.52% |
| 2021 Q4 | 160.44 Million CNY | -39.33% |
| 2021 FY | 956.6 Million CNY | 20.49% |
| 2021 Q3 | 264.47 Million CNY | 21.13% |
| 2021 Q2 | 218.34 Million CNY | -30.32% |
| 2020 Q1 | 75.53 Million CNY | -32.0% |
| 2020 FY | 793.91 Million CNY | 51.15% |
| 2020 Q4 | 227.84 Million CNY | -10.93% |
| 2020 Q3 | 255.79 Million CNY | 8.97% |
| 2020 Q2 | 234.73 Million CNY | 210.75% |
| 2019 Q4 | 111.09 Million CNY | -23.24% |
| 2019 Q3 | 144.73 Million CNY | -4.16% |
| 2019 Q2 | 151.01 Million CNY | 27.52% |
| 2019 FY | 525.26 Million CNY | 18.06% |
| 2019 Q1 | 118.42 Million CNY | 32.42% |
| 2018 Q4 | 89.43 Million CNY | -27.74% |
| 2018 Q2 | 131.38 Million CNY | 30.93% |
| 2018 Q1 | 100.34 Million CNY | 32.2% |
| 2018 FY | 444.92 Million CNY | 18.92% |
| 2018 Q3 | 123.77 Million CNY | -5.79% |
| 2017 Q1 | 80.59 Million CNY | 21.56% |
| 2017 Q2 | 112.21 Million CNY | 39.24% |
| 2017 FY | 374.13 Million CNY | 19.91% |
| 2017 Q3 | 105.42 Million CNY | -6.05% |
| 2017 Q4 | 75.9 Million CNY | -28.0% |
| 2016 Q3 | 80.81 Million CNY | -16.02% |
| 2016 FY | 312.02 Million CNY | 24.29% |
| 2016 Q4 | 66.29 Million CNY | -17.97% |
| 2016 Q2 | 96.23 Million CNY | 40.15% |
| 2016 Q1 | 68.67 Million CNY | 19.97% |
| 2015 Q2 | 87.84 Million CNY | 78.89% |
| 2015 Q1 | 49.1 Million CNY | -2.15% |
| 2015 FY | 251.04 Million CNY | 10.98% |
| 2015 Q4 | 57.24 Million CNY | 0.69% |
| 2015 Q3 | 56.85 Million CNY | -35.28% |
| 2014 FY | 226.21 Million CNY | 17.11% |
| 2014 Q4 | 50.18 Million CNY | -10.12% |
| 2014 Q1 | 44.76 Million CNY | 0.0% |
| 2014 Q3 | 55.83 Million CNY | -25.96% |
| 2014 Q2 | 75.42 Million CNY | 68.48% |
| 2013 FY | 193.15 Million CNY | 22.09% |
| 2012 FY | 158.2 Million CNY | 31.39% |
| 2011 FY | 120.41 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 307.46 Million CNY | -1.677% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion CNY | 84.561% |
| Dirui Industrial Co.,Ltd. | 275.58 Million CNY | -13.436% |
| Beijing Strong Biotechnologies, Inc. | 523.74 Million CNY | 40.311% |
| Medicalsystem Biotechnology Co., Ltd. | 256.55 Million CNY | -21.854% |
| Guangzhou Wondfo Biotech Co.,Ltd | 487.62 Million CNY | 35.89% |
| Guangdong Hybribio Biotech Co.,Ltd. | 140.47 Million CNY | -122.548% |
| BGI Genomics Co., Ltd. | 92.9 Million CNY | -236.509% |
| Amoy Diagnostics Co., Ltd. | 261.48 Million CNY | -19.555% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -141.59 Million CNY | 320.789% |